thyroxine has been researched along with Cholera Infantum in 21 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The preferred treatment for hypothyroidism is oral levothyroxine (LT4) ingestion, in doses that ensure a sustained state of hormonal balance." | 8.88 | The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption. ( Ruchała, M; Szczepanek-Parulska, E; Zybek, A, 2012) |
| "Purpose: to determine lactose intolerance (LI) prevalence in women with Hashimoto’s thyroiditis (HT) and assess the impact of LI on LT4 replacement dose." | 8.12 | Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose. ( Albertelli, M; Bagnasco, M; Bodini, G; Ferone, D; Furnari, M; Giannini, EG; Giusti, M; Marabotto, E; Navarro Rojas, FA; Savarino, E; Savarino, V; Sheijani, AD; Vera, L; Zentilin, P; Ziola, S, 2022) |
| "The clinical courses of galactorrhea and menstrual disorders were studied in 18 women with galactorrhea induced by sulpiride (SLP) or metoclopramide (MCP) given for the treatment of gastrointestinal diseases." | 7.66 | Clinical and endocrinological analyses of patients with galactorrhea and menstrual disorders due to sulpiride or metoclopramide. ( Aono, T; Kinugasa, T; Kurachi, K; Onishi, T; Shioji, T, 1978) |
| "The preferred treatment for hypothyroidism is oral levothyroxine (LT4) ingestion, in doses that ensure a sustained state of hormonal balance." | 4.88 | The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption. ( Ruchała, M; Szczepanek-Parulska, E; Zybek, A, 2012) |
| "Purpose: to determine lactose intolerance (LI) prevalence in women with Hashimoto’s thyroiditis (HT) and assess the impact of LI on LT4 replacement dose." | 4.12 | Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose. ( Albertelli, M; Bagnasco, M; Bodini, G; Ferone, D; Furnari, M; Giannini, EG; Giusti, M; Marabotto, E; Navarro Rojas, FA; Savarino, E; Savarino, V; Sheijani, AD; Vera, L; Zentilin, P; Ziola, S, 2022) |
| "This study compared 2 years of thyroxine treatment with placebo in 196 neonates with Down syndrome who were included in a previously reported randomized clinical trial." | 3.73 | Comorbidity, hospitalization, and medication use and their influence on mental and motor development of young infants with Down syndrome. ( de Vijlder, JJ; Heymans, HS; Tijssen, JG; van Trotsenburg, AS; Vulsma, T, 2006) |
| " Vitamin A therapy in patients with documented vitamin A deficiency produced an increase in T3, thyroxine (T4), FT3I, FT4I, and free T3 by dialysis, with a concomitant increase in retinol binding protein and no alteration in prealbumin concentrations." | 3.66 | The interrelationship of thyroid hormones with vitamin A and zinc nutritional status in patients with chronic hepatic and gastrointestinal disorders. ( Carney, EA; Hershman, JM; Morley, JE; Reed, A; Russell, RM, 1981) |
| "The clinical courses of galactorrhea and menstrual disorders were studied in 18 women with galactorrhea induced by sulpiride (SLP) or metoclopramide (MCP) given for the treatment of gastrointestinal diseases." | 3.66 | Clinical and endocrinological analyses of patients with galactorrhea and menstrual disorders due to sulpiride or metoclopramide. ( Aono, T; Kinugasa, T; Kurachi, K; Onishi, T; Shioji, T, 1978) |
| "The impact of gastrointestinal disorders on T4 treatment efficacy has been also analyzed, in keeping with the site of action and the interfering mechanisms." | 2.61 | Gastrointestinal Malabsorption of Thyroxine. ( Antonelli, A; Benvenga, S; Centanni, M; Santaguida, MG; Virili, C, 2019) |
| "Compliance to levothyroxine treatment in hypothyroidism is compromised by daily and fasting schedule." | 2.58 | MANAGEMENT OF ENDOCRINE DISEASE: Pitfalls on the replacement therapy for primary and central hypothyroidism in adults. ( de Carvalho, GA; Graf, H; Mesa Junior, C; Paz-Filho, G, 2018) |
| "Many gastrointestinal disorders, such as celiac disease, atrophic gastritis, lactose intolerance, and Helicobacter pylori infection, may impede the absorption of levothyroxine." | 2.55 | Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review. ( Amidžić Klarić, D; Bakula, M; Gharib, H; Liberati-Čizmek, AM; Lucijanić, T; Rahelić, D; Rešić, A; Skelin, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (47.62) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Marabotto, E | 1 |
| Ferone, D | 1 |
| Sheijani, AD | 1 |
| Vera, L | 1 |
| Ziola, S | 1 |
| Savarino, E | 1 |
| Bodini, G | 1 |
| Furnari, M | 1 |
| Zentilin, P | 1 |
| Savarino, V | 1 |
| Giusti, M | 1 |
| Navarro Rojas, FA | 1 |
| Bagnasco, M | 1 |
| Albertelli, M | 1 |
| Giannini, EG | 1 |
| de Carvalho, GA | 1 |
| Paz-Filho, G | 1 |
| Mesa Junior, C | 1 |
| Graf, H | 1 |
| Virili, C | 2 |
| Antonelli, A | 1 |
| Santaguida, MG | 2 |
| Benvenga, S | 1 |
| Centanni, M | 2 |
| Korkmaz, L | 1 |
| Akın, MA | 1 |
| Güneş, T | 1 |
| Daar, G | 1 |
| Baştuğ, O | 1 |
| Yıkılmaz, A | 1 |
| Kurtoğlu, S | 1 |
| Skelin, M | 1 |
| Lucijanić, T | 1 |
| Amidžić Klarić, D | 1 |
| Rešić, A | 1 |
| Bakula, M | 1 |
| Liberati-Čizmek, AM | 1 |
| Gharib, H | 1 |
| Rahelić, D | 1 |
| Ruchała, M | 1 |
| Szczepanek-Parulska, E | 1 |
| Zybek, A | 1 |
| de Luis, DA | 1 |
| Abad, L | 1 |
| Aller, R | 1 |
| González-Sagrado, M | 1 |
| Dueñas, A | 1 |
| van Trotsenburg, AS | 1 |
| Heymans, HS | 1 |
| Tijssen, JG | 1 |
| de Vijlder, JJ | 1 |
| Vulsma, T | 1 |
| Franchi, A | 1 |
| Nardo, S | 1 |
| Gargano, L | 1 |
| Pingleton, SK | 1 |
| Morley, JE | 1 |
| Russell, RM | 1 |
| Reed, A | 1 |
| Carney, EA | 1 |
| Hershman, JM | 1 |
| Kraft, W | 1 |
| Dietl, A | 1 |
| Seppel, T | 1 |
| Becker, A | 1 |
| Lippert, F | 1 |
| Schlaghecke, R | 1 |
| Geiter, B | 1 |
| Helenius, T | 1 |
| Liewendahl, K | 1 |
| Aono, T | 1 |
| Shioji, T | 1 |
| Kinugasa, T | 1 |
| Onishi, T | 1 |
| Kurachi, K | 1 |
| Carter, JN | 1 |
| Corcoran, JM | 1 |
| Eastman, CJ | 1 |
| Lazarus, L | 1 |
| O'Halloran, M | 1 |
| Hays, MT | 1 |
| Ruppert, F | 1 |
| Sulyok, E | 1 |
| Sárkány, I | 1 |
| Zámbó, K | 1 |
| Csaba, IF | 1 |
| Green, D | 1 |
| Smith, NJ | 1 |
| Hedley, AJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism Requiring High Levothyroxine Dosage; a Randomized Control Trial[NCT05733078] | Phase 2 | 40 participants (Anticipated) | Interventional | 2023-04-30 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for thyroxine and Cholera Infantum
| Article | Year |
|---|---|
MANAGEMENT OF ENDOCRINE DISEASE: Pitfalls on the replacement therapy for primary and central hypothyroidism in adults.
Topics: Adult; Disease Management; Drug Interactions; Gastrointestinal Diseases; Hormone Replacement Therapy | 2018 |
Gastrointestinal Malabsorption of Thyroxine.
Topics: Drug Interactions; Gastrointestinal Absorption; Gastrointestinal Diseases; Humans; Hypothyroidism; P | 2019 |
Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review.
Topics: Gastrointestinal Diseases; Humans; Intestinal Absorption; Proton Pump Inhibitors; Thyrotropin; Thyro | 2017 |
The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption.
Topics: Celiac Disease; Diet, Gluten-Free; Dose-Response Relationship, Drug; Drug Resistance; Gastrointestin | 2012 |
[Levothyroxine poisoning: clinical manifestations and therapeutic management].
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Cardiovascular Diseases; Child; Cholestyramine Resi | 2004 |
[Oral thyroxine treatment: towards an individually tailored dose].
Topics: Absorption; Administration, Oral; Adult; Age Factors; Biomarkers; Drug Administration Schedule; Drug | 2007 |
Complications of acute respiratory failure.
Topics: Acute Disease; Barotrauma; Cardiovascular Diseases; Gastrointestinal Diseases; Hematologic Diseases; | 1983 |
Thyroid hormone and the gut.
Topics: Animals; Biological Availability; Digestive System Physiological Phenomena; Gastrointestinal Disease | 1988 |
Hemophilia. Current concepts in management.
Topics: Adrenal Cortex Hormones; Adult; Analgesics; Antifibrinolytic Agents; Blood Transfusion; Cardiovascul | 1972 |
Myxoedema.
Topics: Anemia; Blood Coagulation Disorders; Central Nervous System Diseases; Electrocardiography; Female; G | 1972 |
11 other studies available for thyroxine and Cholera Infantum
| Article | Year |
|---|---|
Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose.
Topics: Adult; Aged; Female; Gastrointestinal Diseases; Hashimoto Disease; Humans; Lactose; Lactose Intolera | 2022 |
Unusual course of congenital hypothyroidism and route of the L-thyroxine treatment in a preterm newborn.
Topics: Administration, Oral; Biological Availability; Cholestasis, Intrahepatic; Congenital Hypothyroidism; | 2014 |
Comorbidity, hospitalization, and medication use and their influence on mental and motor development of young infants with Down syndrome.
Topics: Child Development; Child, Preschool; Comorbidity; Congenital Hypothyroidism; Double-Blind Method; Do | 2006 |
The interrelationship of thyroid hormones with vitamin A and zinc nutritional status in patients with chronic hepatic and gastrointestinal disorders.
Topics: Chronic Disease; Gastrointestinal Diseases; Humans; Liver Cirrhosis; Retinol-Binding Proteins; Thyro | 1981 |
[Total thyroxine (T4) and free thyroxine (FT4) in hypothyroidism and nonthyroid diseases of dogs].
Topics: Alopecia; Animals; Cushing Syndrome; Diabetes Complications; Diabetes Mellitus; Dog Diseases; Dogs; | 1994 |
Serum sex hormone-binding globulin and osteocalcin in systemic nonthyroidal illness associated with low thyroid hormone concentrations.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases; Communicable Diseases; Female; | 1996 |
[Rational laboratory diagnosis in general practice: thyroid diseases, hypertension, gastrointestinal tract].
Topics: Clinical Laboratory Techniques; Diagnosis, Differential; Duodenum; Gastrointestinal Diseases; Giardi | 1978 |
Abnormal thyroid function tests in devere non-thyroidal illness: diagnostic and pathophysiologic aspects.
Topics: Adult; Aged; Cardiovascular Diseases; Fatty Acids, Nonesterified; Female; Gastrointestinal Diseases; | 1979 |
Clinical and endocrinological analyses of patients with galactorrhea and menstrual disorders due to sulpiride or metoclopramide.
Topics: Adult; Female; Follicle Stimulating Hormone; Galactorrhea; Gastrointestinal Diseases; Gonadotropin-R | 1978 |
Serum T3 and T4 levels in sick children.
Topics: Adolescent; Burns; Child; Child, Preschool; Gastrointestinal Diseases; Humans; Infant; Infant, Newbo | 1976 |
Effect of metoclopramide treatment on thyrotropin and prolactin levels in sick neonates.
Topics: Gastrointestinal Diseases; Humans; Infant, Newborn; Male; Metoclopramide; Prolactin; Receptors, Dopa | 1986 |